Prevalence of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis in Benin
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Introduction: The diagnosis of Juvenile Idiopathic Arthritis (JIA) is difficult in sub-Saharan countries due to the
complexity and polymorphism of the disease. JIA can be
accompanied by the presence of Anti-Cyclic Citrullinated
Peptide Antibodies (ACPA). This work aims to determine the
prevalence of ACPA among children suffering from juvenile
idiopathic arthritis in Benin.
Patients and methods: A descriptive cross-sectional
study over 5 years was conducted in the rheumatology and
pediatric departments of National Hospital University Hubert Koutoukou Maga of Cotonou among children suffering from osteoarticular disorders. ACPA were checked by
an Enzyme Linked Immunosorbent Assay (ELISA) in serum
samples from patients with JIA. Which had been retained
using ILAR criteria. The data collected was analyzed using
SPSS 20.0 software.
Results: Among 179 children treated for osteo-articular
disorders, 32 (17.8%) had JIA. There were 19 girls and 13
boys. The teenagers’ group (range from 13 to 16 years old)
was the most represented age group (53.1%). Polyarthritis
was the most common symptom for reasons of consultation or hospitalization (63%). The most common form of JIA
in our series was enthesitis-related arthritis (9 i.e. 28.1%)
that affected female teenagers (sex ratio=0.8), followed by
Rheumatoid Factor (RF)-positive polyarthritis (8 i.e. 25%)
which were frequent in the female child (7-12 years old). Biological inflammatory syndrome was present in all children.
ACPA were present in 28.1% of JIA cases, including 55.6% of
RF positive polyarthritis.
Conclusion: Prevalence of ACPA remains relatively high
among children suffering from JIA in the Beninese population. Its high presence in teenagers probably suggests that it
is early juvenile rheumatoid arthritis. It is important to conduct further studies to better clarify the role of antibodies in
the course of the disease.
